Does Skinvive Fill Hollow Cheeks?

Skinvive should be understood as a treatment for cheek skin smoothness, rather than a way to restore volume to hollow cheeks. At UH CELL, we distinguish these goals: sharing the ingredient hyaluronic acid does not make skin-smoothing treatment and volume replacement the same thing.

Smoother skin and fuller cheeks are different goals

According to the U.S. Food and Drug Administration’s 2023 approval information, Skinvive is injected into the dermis, a layer of the skin, to improve cheek skin smoothness. This describes its U.S. approval, not its regulatory status in South Korea.

In its 2023 announcement, manufacturer Allergan Aesthetics also described Skinvive as a hyaluronic acid gel for improving cheek skin smoothness. The ingredient name alone is not a reason to choose it for the same purpose as a treatment intended to fill hollow cheeks.

If hollow cheeks are your main concern, explain whether you want to fill a sunken area or improve the smoothness of the skin over your cheeks.

What the clinical evidence supports

The FDA’s approval information describes a clinical trial involving 209 participants that evaluated improvement in cheek skin smoothness. That result cannot be used as evidence that Skinvive restores lost cheek volume.

This does not mean that no one could experience any change in shape. It means the skin-smoothness findings do not establish the volume-restoring benefit someone with hollow cheeks may be seeking.

We keep that distinction central to expectations: evidence for smoother skin should not be treated as evidence for fuller cheeks.

Injection risks also matter

The 2023 U.S. patient labeling published by the FDA lists injection-site reactions such as swelling, bruising, and pain. It also warns that accidental injection into a blood vessel, although rare, can cause serious complications, including vision impairment, blindness, stroke, and permanent scarring.

Tell the treating medical team immediately and seek urgent medical attention if you develop any of the following during or shortly after treatment:

• Changes in vision.
• Skin turning white.
• Unusual pain.

Share your allergy history before treatment

The same FDA-published patient labeling lists the following as contraindications, meaning circumstances in which the product should not be used:

• A history of anaphylaxis or multiple severe allergies.
• An allergy to lidocaine or gram-positive bacterial proteins.
• A previous allergic reaction to hyaluronic acid fillers.

Before treatment, discuss both the change you want and your allergy history with the medical team. For hollow cheeks, the key question is whether the plan addresses lost volume, skin smoothness, or both, rather than assuming that one goal includes the other.

Skin reactions and recovery time vary from person to person. Consult a medical professional for an individual assessment and treatment plan.